A new hybrid diffuse optical platform was developed with fast, time-resolved and correlation spectroscopied. We present the device and results from an on-going clinical trial to evaluate hemodynamic and metabolic biomarkers for guiding acute ischemic stroke management.

© 2020 The Author(s)

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription